CANC Holdings Information

CANC is an equity ETF with a total of 60 individual holdings. The top holdings are Revolution Medicines stock at 6.29%, Eli Lilly and Company at 5.48%, Cogent Biosciences at 4.84%, Roche Holding AG at 4.38%, and Novartis AG at 3.84%.

Total Holdings

Top 10 Percentage

41.78%

Asset Class

Equity

ETF Category

Health

Assets

210.24M

PE Ratio

19.80

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	RVMD	Revolution Medicines, Inc.	6.29%	63,643
2	LLY	Eli Lilly and Company	5.48%	9,252
3	COGT	Cogent Biosciences, Inc.	4.84%	265,122
4	RHHBY	Roche Holding AG	4.38%	161,380
5	SWX: NOVN	Novartis AG	3.84%	51,609
6	MRK	Merck & Co., Inc.	3.57%	53,828
7	ABBV	AbbVie Inc.	3.56%	28,967
8	BMY	Bristol-Myers Squibb Company	3.52%	111,076
9	ONC	BeOne Medicines AG	3.20%	18,365
10	JNJ	Johnson & Johnson	3.10%	24,155
11	HALO	Halozyme Therapeutics, Inc.	3.06%	62,133
12	IMNM	Immunome, Inc.	2.94%	227,174
13	AMGN	Amgen Inc.	2.84%	13,885
14	CGON	CG Oncology, Inc.	2.79%	76,283
15	GMAB	Genmab A/S	2.77%	180,357
16	IDYA	IDEAYA Biosciences, Inc.	2.51%	139,943
17	EXEL	Exelixis, Inc.	2.47%	99,805
18	ELVN	Enliven Therapeutics, Inc.	2.08%	73,262
19	ZLAB	Zai Lab Limited	2.02%	158,638
20	LON: AZN	AstraZeneca PLC	1.98%	25,559
21	LEGN	Legend Biotech Corporation	1.93%	194,694
22	BBIO	BridgeBio Pharma, Inc.	1.86%	46,830
23	ERAS	Erasca, Inc.	1.79%	204,789
24	CELC	Celcuity Inc.	1.79%	42,141
25	RLAY	Relay Therapeutics, Inc.	1.78%	182,110

Showing 25 of 60 holdings

Subscribe to see the full list

Activate Now

As of Aug 13, 2026